RHOA and mature T-cell and NK-cell non-Hodgkin lymphoma: To rule out the possibility that dasatinib activity could be related to the presence of activating mutations in genes related to TCR signalling such as FYN and RHOA that have been recently reported in a significant fraction of PTCL patients,38 Sanger sequencing was performed.